Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Angermeier

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Urology|January 31, 2004
PSA bounce predicts early success in patients with permanent iodine-125 prostate implantChandrika Patel, Mohamed A Elshaikh, Kenneth Angermeier, et al.
Urology|December 16, 2006
Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostateAimee L Quan, Jay P Ciezki, Chandana A Reddy, et al.
Urology|February 1, 2003
Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapyMohamed A Elshaikh, Kenneth Angermeier, James C Ulchaker, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancerMichael J Burdick, Chandana A Reddy, James Ulchaker, et al.
Practical Radiation Oncology|April 23, 2015
Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitisSheen Cherian, Jeffrey A Kittel, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate CancerJay P Ciezki, Michael Weller, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2015
Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate CancerJeffrey A Kittel, Chandana A Reddy, Kristin L Smith, et al.
Brachytherapy|December 10, 2019
Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapyMartin C Tom, Chandana A Reddy, Timothy D Smile, et al.
Urology|December 11, 2017
Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective AnalysisKenneth J DeLay, Nora M Haney, Jason Chiang, et al.
Brachytherapy|October 17, 2021
<sup>125</sup>I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancerTimothy D Smile, Martin C Tom, Ahmed Halima, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Urology|January 31, 2004
PSA bounce predicts early success in patients with permanent iodine-125 prostate implantChandrika Patel, Mohamed A Elshaikh, Kenneth Angermeier, et al.
Urology|December 16, 2006
Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostateAimee L Quan, Jay P Ciezki, Chandana A Reddy, et al.
Urology|February 1, 2003
Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapyMohamed A Elshaikh, Kenneth Angermeier, James C Ulchaker, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2008
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancerMichael J Burdick, Chandana A Reddy, James Ulchaker, et al.
Practical Radiation Oncology|April 23, 2015
Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitisSheen Cherian, Jeffrey A Kittel, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate CancerJay P Ciezki, Michael Weller, Chandana A Reddy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2015
Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²⁵I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate CancerJeffrey A Kittel, Chandana A Reddy, Kristin L Smith, et al.
Brachytherapy|December 10, 2019
Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapyMartin C Tom, Chandana A Reddy, Timothy D Smile, et al.
Urology|December 11, 2017
Comparison of Adjuvant Radiation Therapy Before or After Artificial Urinary Sphincter Placement: A Multi-Institutional, Retrospective AnalysisKenneth J DeLay, Nora M Haney, Jason Chiang, et al.
Brachytherapy|October 17, 2021
<sup>125</sup>I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancerTimothy D Smile, Martin C Tom, Ahmed Halima, et al.
Pageof 3